While patients in Massachusetts await affordable doses of the blockbuster hepatitis C drug Sovaldi, Rep. Joseph Kennedy III has financially benefited from the success of the drug’s manufacturer, Gilead Sciences, according to public financial disclosures and campaign finance records. And he�
Source: Sky-high price of hepatitis C drug produces profits for lawmakers | OpenSecrets Blog
John Barleycorn 